Goldman Sachs Group »

Dianthus Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.6M 219k 39.35
2025-03-31 $1.3M 73k 18.14
2024-12-31 $4.5M 208k 21.80
2024-09-30 $2.2M 81k 27.38
2024-06-30 $1.1M 42k 25.88
2024-03-31 $5.1M 170k 30.00